BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33864024)

  • 1. CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.
    Marayati R; Stafman LL; Williams AP; Bownes LV; Quinn CH; Markert HR; Easlick JL; Stewart JE; Crossman DK; Mroczek-Musulman E; Beierle EA
    Cancer Gene Ther; 2022 May; 29(5):558-572. PubMed ID: 33864024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4.
    Marayati R; Julson J; Bownes LV; Quinn CH; Stafman LL; Beierle AM; Markert HR; Hutchins SC; Stewart JE; Crossman DK; Hjelmeland AB; Mroczek-Musulman E; Beierle EA
    Clin Exp Metastasis; 2022 Dec; 39(6):899-912. PubMed ID: 36315303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.
    Stafman LL; Waldrop MG; Williams AP; Aye JM; Stewart JE; Mroczek-Musulman E; Yoon KJ; Whelan K; Beierle EA
    J Pediatr Surg; 2019 Jun; 54(6):1206-1213. PubMed ID: 30898394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG1 Accelerates Cell Proliferation, Migration, and Invasion of Hepatoblastoma Through Mediating miR-6838-5p/PIM3/RhoA Axis.
    Zhang T; Ji C; Zhang Y; Yuan M; Gao H; Yin Q
    Biochem Genet; 2024 Feb; 62(1):59-76. PubMed ID: 37248373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.
    Marayati R; Stafman LL; Williams AP; Bownes LV; Quinn CH; Aye JM; Stewart JE; Yoon KJ; Anderson JC; Willey CD; Beierle EA
    Sci Rep; 2021 Mar; 11(1):5984. PubMed ID: 33727604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA‑506 participates in pancreatic cancer pathogenesis by targeting PIM3.
    Du J; Zheng X; Cai S; Zhu Z; Tan J; Hu B; Huang Z; Jiao H
    Mol Med Rep; 2015 Oct; 12(4):5121-6. PubMed ID: 26238203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastoma.
    Wadhwani N; Markert HR; Marayati R; Bownes LV; Quinn CH; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    J Pediatr Surg; 2021 Jun; 56(6):1157-1164. PubMed ID: 33762119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-126 in Extracellular Vesicles Derived from Hepatoblastoma Cells Promotes the Tumorigenesis of Hepatoblastoma through Inducing the Differentiation of BMSCs into Cancer Stem Cells.
    Hu Y; Zai H; Jiang W; Yao Y; Ou Z; Zhu Q
    J Immunol Res; 2021; 2021():6744715. PubMed ID: 34746322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.
    Stafman LL; Mruthyunjayappa S; Waters AM; Garner EF; Aye JM; Stewart JE; Yoon KJ; Whelan K; Mroczek-Musulman E; Beierle EA
    Oncotarget; 2018 Apr; 9(32):22665-22679. PubMed ID: 29854306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on Hepatoblastoma.
    Bownes LV; Julson JR; Quinn CH; Hutchins SC; Erwin MH; Markert HR; Stewart JE; Mroczek-Musulman E; Aye J; Yoon KJ; Ohlmeyer M; Beierle EA
    J Pediatr Surg; 2023 Jun; 58(6):1145-1154. PubMed ID: 36907775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma.
    Stafman LL; Williams AP; Garner EF; Aye JM; Stewart JE; Yoon KJ; Whelan K; Beierle EA
    Transl Oncol; 2019 Feb; 12(2):200-208. PubMed ID: 30412911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma.
    Julson JR; Quinn CH; Butey S; Erwin MH; Marayati R; Nazam N; Stewart JE; Beierle EA
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIM3 Functions as Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer.
    Qi Q; Pan Y; Han S; Liao H; Jiang Y; Shen J; Zhong L; Wang X; Chen J
    Anat Rec (Hoboken); 2019 Sep; 302(9):1552-1560. PubMed ID: 30417983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells.
    Soini T; Eloranta K; Pihlajoki M; Kyrönlahti A; Akinrinade O; Andersson N; Lohi J; Pakarinen MP; Wilson DB; Heikinheimo M
    Tumour Biol; 2018 Jul; 40(7):1010428318785498. PubMed ID: 30074440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells.
    Zhang F; Liu R; Zhang H; Liu C; Liu C; Lu Y
    BMC Cancer; 2020 Jul; 20(1):673. PubMed ID: 32682409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells.
    Yang F; Cui P; Lu Y; Zhang X
    Stem Cell Res Ther; 2019 Aug; 10(1):233. PubMed ID: 31375149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
    Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
    J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.
    Forshell LP; Li Y; Forshell TZ; Rudelius M; Nilsson L; Keller U; Nilsson J
    Oncotarget; 2011 Jun; 2(6):448-60. PubMed ID: 21646687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.